D
Recursion Pharmaceuticals, Inc. RXRX
$6.35 $0.416.90%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -86.67% 1.74% -6.75% 1.75% 0.02%
Total Depreciation and Amortization 79.92% -19.74% 21.57% -2.33% -0.33%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 66.25% 61.00% -8.43% -19.83% 33.30%
Change in Net Operating Assets 126.86% 125.97% 71.84% -223.43% -152.58%
Cash from Operations -94.90% 27.97% 19.63% -38.10% -1.59%
Capital Expenditure 71.55% -285.96% 82.23% -221.87% -177.45%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- 100.00% -- -- -187.94%
Cash from Investing 6,138.05% -9.09% 37.14% -167.40% -617.00%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 8.13% -8,696.15% 0.00% 96.25% -2,791.67%
Issuance of Common Stock -32.05% -92.88% 1,790.02% -82.89% 51.24%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -35.37% -93.74% 1,793.37% -82.77% 50.02%
Foreign Exchange rate Adjustments -961.54% 441.53% 46.12% -276.61% 207.83%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 456.32% -126.57% 285.36% -2,358.77% 121.50%
Weiss Ratings